Search results for CD161 antibody

APC/Cy7® Anti-CD161 antibody [HP-3G10], Abcam, AB270677

This product or portions thereof is manufactured under license from Carnegie Mellon University under U.S. Patent Number 5, 268, 486 and related patents. Cy® and CyDye® are trademarks of Cytiva.

Anti-CD161 antibody [EPR23831-120] - BSA and Azide free, Abcam, AB280203

ab280203 is the carrier-free version of ab259916 . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Conjugation ready Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications. Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold. Compatibility This product is compatible with the Maxpar ® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar ® is a trademark of Fluidigm Canada Inc.

Anti-CD161 antibody [EPR26340-6] (BSA and Azide free), Abcam, AB302565

Want a custom formulation? This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact [email protected] Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Conjugation ready Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications. Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

PE/Cyanine7 anti-human CD161 Antibody, CD161, W18070C, BioLegend, 307505

PE/Cyanine7 anti-human CD161 Antibody, CD161, W18070C, BioLegend, 307506

PE/Cyanine7 anti-rat CD161 Antibody, CD161, 3.2.3, BioLegend, 205609

3.2.3 recognizes a common epitope of NKR-1P1a (CD161a) and NKR-P1b (CD161b).

PE/Cyanine7 anti-rat CD161 Antibody, CD161, 3.2.3, BioLegend, 205610

3.2.3 recognizes a common epitope of NKR-1P1a (CD161a) and NKR-P1b (CD161b).

PE/Cyanine5 anti-rat CD161 antibody, CD161, 3.2.3, BioLegend, 205611

3.2.3 recognizes a common epitope of NKR-1P1a (CD161a) and NKR-P1b (CD161b).

PE/Cyanine5 anti-rat CD161 antibody, CD161, 3.2.3, BioLegend, 205612

3.2.3 recognizes a common epitope of NKR-1P1a (CD161a) and NKR-P1b (CD161b).

FITC anti-rat CD161 Antibody anti-CD161 - 3.2.3, BioLegend, 205608

3.2.3 recognizes a common epitope of NKR-1P1a (CD161a) and NKR-P1b (CD161b).